Skip to main content
AMINOLOGICS CO.,LTD. logo

AMINOLOGICS CO.,LTD. — Investor Relations & Filings

Ticker · 074430 ISIN · KR7074430000 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2025-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 074430

About AMINOLOGICS CO.,LTD.

https://aminologics.co.kr/eng/main/

AMINOLOGICS CO.,LTD. is a specialty manufacturer of amino acids and their derivatives. The company's core competency is its proprietary chiral resolution platform technology, ARCA (Alanine Racemase Chiral). This innovative enzymatic process enables the cost-effective production of a wide range of high-purity chiral amino acids. These products serve as essential building blocks and Active Pharmaceutical Ingredients (APIs) for various sectors, including the pharmaceutical, fine chemical, agrochemical, and life science industries. The technology allows for the development of new products and treatments by providing materials with high optical purity at a reduced cost.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted by AminoLogics. It provides the audit opinion, key financial data (assets, liabilities, equity, revenue, profit/loss), and details regarding the external auditor. While it contains financial data, it is a specific regulatory disclosure of the audit results rather than the full 10-K annual report or a simple announcement of report publication. In the context of Korean regulatory filings (DART), this is classified as an Audit Report/Information filing. FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 28th fiscal year (2024) of Aminologics Co., Ltd. It contains detailed financial information, business descriptions, management discussions, and corporate governance details, which are characteristic of a comprehensive annual report. In the Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K filing. FY 2024
2025-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for AminoLogics Co., Ltd. It includes the meeting date, location, agenda items (financial statement approval, director/auditor appointments, remuneration limits), and proxy voting instructions. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and proxy solicitation details. While it includes financial statements, these are provided as supporting information for the shareholder meeting agenda rather than as a standalone Annual Report (10-K). Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Aminologics. It outlines the date, location, agenda items (such as financial statement approval and auditor appointment), and voting procedures. This document is a standard proxy solicitation/notice of meeting material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of Proxy Solicitation & Information Statement (PSI).
2025-02-28 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (AminoLogics) regarding a correction to a previously filed report on financial performance (specifically, a change in revenue or profit/loss structure exceeding 30%). This type of filing is a standard regulatory disclosure required by the Korea Exchange (KRX) when financial figures are updated or corrected. Since it is a specific regulatory announcement regarding financial data updates rather than a full annual report or a simple report publication notice, it falls under the 'Regulatory Filings' category. FY 2024
2025-02-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.